• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

低风险分化型甲状腺癌的非手术治疗

Nonoperative management of low-risk differentiated thyroid carcinoma.

作者信息

Ito Yasuhiro, Miyauchi Akira

机构信息

aDepartment of Surgery bClinical Trial Management Center, Kuma Hospital, Center for Excellence in Thyroid Care, Kobe, Japan.

出版信息

Curr Opin Oncol. 2015 Jan;27(1):15-20. doi: 10.1097/CCO.0000000000000143.

DOI:10.1097/CCO.0000000000000143
PMID:25340592
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC4255758/
Abstract

PURPOSE OF REVIEW

The global incidence of small papillary thyroid carcinoma (PTC) is increasing remarkably, mostly due to the increased use of imaging studies worldwide. The issue of how to manage low-risk small PTC has become urgent. In this review, we focus on how to treat low-risk papillary thyroid microcarcinomas (PMCs; i.e., PTCs measuring ≤10 mm).

RECENT FINDINGS

Studies of large numbers of patients with low-risk PMC clarified that most of the PMCs did not grow or grew very slowly and were harmless. Active observations of these patients discriminated rare progressive cases from the majority. Surgery performed after the detection of progression signs was not too late, and surgery immediately after the detection and diagnosis of low-risk PMC may be overtreatment for most patients. Interestingly, low-risk PMCs in elderly patients were most unlikely to progress, in sharp contrast to clinical PTC. The reason for this phenomenon remains unknown.

SUMMARY

Active observation without immediate surgery can be a leading alternative to the classical surgical treatment in the majority of the patients with low-risk PMC. It is not too late to perform surgery after the detection of progression signs for these patients.

VIDEO ABSTRACT

http://links.lww.com/COON/A10

摘要

综述目的

全球小乳头状甲状腺癌(PTC)的发病率显著上升,主要归因于全球范围内影像学检查使用的增加。如何处理低风险小PTC的问题变得紧迫。在本综述中,我们聚焦于如何治疗低风险甲状腺微小乳头状癌(PMCs;即直径≤10毫米的PTC)。

最新发现

对大量低风险PMC患者的研究表明,大多数PMC不会生长或生长非常缓慢且无害。对这些患者进行积极观察可将罕见的进展性病例与大多数病例区分开来。在出现进展迹象后进行手术并不太晚,而在检测和诊断低风险PMC后立即进行手术对大多数患者可能属于过度治疗。有趣的是,老年患者中的低风险PMC最不可能进展,这与临床PTC形成鲜明对比。这种现象的原因尚不清楚。

总结

对于大多数低风险PMC患者,不立即手术而是进行积极观察可以成为经典手术治疗的主要替代方案。对这些患者在出现进展迹象后进行手术并不太晚。

视频摘要

http://links.lww.com/COON/A10

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/4255758/c12541b0ada7/coonc-27-15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/4255758/c12541b0ada7/coonc-27-15-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b664/4255758/c12541b0ada7/coonc-27-15-g001.jpg

相似文献

1
Nonoperative management of low-risk differentiated thyroid carcinoma.低风险分化型甲状腺癌的非手术治疗
Curr Opin Oncol. 2015 Jan;27(1):15-20. doi: 10.1097/CCO.0000000000000143.
2
Insights into the Management of Papillary Microcarcinoma of the Thyroid.甲状腺微小乳头状癌的处理要点。
Thyroid. 2018 Jan;28(1):23-31. doi: 10.1089/thy.2017.0227. Epub 2017 Sep 22.
3
Effects of Pregnancy on Papillary Microcarcinomas of the Thyroid Re-Evaluated in the Entire Patient Series at Kuma Hospital.在熊本医院的所有患者系列中重新评估妊娠对甲状腺微小乳头状癌的影响。
Thyroid. 2016 Jan;26(1):156-60. doi: 10.1089/thy.2015.0393. Epub 2015 Dec 15.
4
Low-risk papillary microcarcinoma of the thyroid: A review of active surveillance trials.低危甲状腺微小乳头状癌:主动监测试验的回顾。
Eur J Surg Oncol. 2018 Mar;44(3):307-315. doi: 10.1016/j.ejso.2017.03.004. Epub 2017 Mar 16.
5
Active Surveillance as First-Line Management of Papillary Microcarcinoma.主动监测作为甲状腺微小乳头状癌的一线治疗方法。
Annu Rev Med. 2019 Jan 27;70:369-379. doi: 10.1146/annurev-med-051517-125510. Epub 2018 Sep 19.
6
Active Surveillance Versus Immediate Surgery: Questionnaire Survey on the Current Treatment Strategy for Adult Patients with Low-Risk Papillary Thyroid Microcarcinoma in Japan.主动监测与即刻手术:日本低危型甲状腺微小乳头状癌成年患者当前治疗策略的问卷调查
Thyroid. 2019 Nov;29(11):1563-1571. doi: 10.1089/thy.2019.0211. Epub 2019 Sep 25.
7
A Clinical Framework to Facilitate Risk Stratification When Considering an Active Surveillance Alternative to Immediate Biopsy and Surgery in Papillary Microcarcinoma.在考虑对乳头状微小癌采用主动监测替代立即活检和手术时,用于促进风险分层的临床框架。
Thyroid. 2016 Jan;26(1):144-9. doi: 10.1089/thy.2015.0178. Epub 2015 Nov 5.
8
Incidences of Unfavorable Events in the Management of Low-Risk Papillary Microcarcinoma of the Thyroid by Active Surveillance Versus Immediate Surgery.通过主动监测与立即手术治疗低风险甲状腺乳头状微小癌过程中不良事件的发生率
Thyroid. 2016 Jan;26(1):150-5. doi: 10.1089/thy.2015.0313. Epub 2015 Nov 5.
9
Insights and clinical questions about the active surveillance of low-risk papillary thyroid microcarcinomas [Review].关于低风险甲状腺微小乳头状癌主动监测的见解与临床问题[综述]
Endocr J. 2016 Apr 25;63(4):323-8. doi: 10.1507/endocrj.EJ15-0637. Epub 2015 Dec 2.
10
Clinicians' Views on Management and Terminology for Papillary Thyroid Microcarcinoma: A Qualitative Study.临床医生对甲状腺微小乳头状癌管理及术语的看法:一项定性研究
Thyroid. 2017 May;27(5):661-671. doi: 10.1089/thy.2016.0483. Epub 2017 Mar 21.

引用本文的文献

1
Retrospective Analysis of the Efficacy and Safety of Ultrasound-Guided Radiofrequency Ablation in the Treatment of Papillary Thyroid Microcarcinoma: A Follow-Up Study of Continuous Postoperative Surveillance and Large-Sample Data.超声引导下射频消融治疗甲状腺微小乳头状癌的疗效与安全性回顾性分析:术后连续监测及大样本数据的随访研究
Int J Endocrinol. 2024 Mar 6;2024:2704087. doi: 10.1155/2024/2704087. eCollection 2024.
2
Editorial: Does Every Thyroid Cancer Patient Need Surgery?社论:每位甲状腺癌患者都需要手术吗?
Rambam Maimonides Med J. 2022 Apr 26;13(2):e0014. doi: 10.5041/RMMJ.10471.
3
Comparison between 2015 ATA guidelines and Italian Consensus for DTC management. A commented report.

本文引用的文献

1
Current thyroid cancer trends in the United States.美国当前的甲状腺癌趋势。
JAMA Otolaryngol Head Neck Surg. 2014 Apr;140(4):317-22. doi: 10.1001/jamaoto.2014.1.
2
Papillary thyroid microcarcinoma might progress during pregnancy.甲状腺微小乳头状癌在孕期可能会进展。
Thyroid. 2014 May;24(5):840-4. doi: 10.1089/thy.2013.0527. Epub 2014 Mar 6.
3
Association between serum thyrotropin concentration and growth of asymptomatic papillary thyroid microcarcinoma.血清促甲状腺激素浓度与无症状性甲状腺微小乳头状癌生长之间的关联。
2015年美国甲状腺协会(ATA)指南与意大利分化型甲状腺癌(DTC)管理共识的比较。一篇评论报告。
Acta Otorhinolaryngol Ital. 2022 Feb;42(1):41-54. doi: 10.14639/0392-100X-N1572.
4
Differentiated Thyroid Cancer: A Health Economic Review.分化型甲状腺癌:健康经济学综述。
Cancers (Basel). 2021 May 7;13(9):2253. doi: 10.3390/cancers13092253.
5
Use and overuse of diagnostic neck ultrasound in Ontario: Retrospective population-based cohort study.安大略省颈部超声诊断的使用与过度使用:基于人群的回顾性队列研究。
Can Fam Physician. 2020 Feb;66(2):e62-e68.
6
Evaluation of MEDAG gene expression in papillary thyroid microcarcinoma: associations with histological features, regional lymph node metastasis and prognosis.评价 MEDAG 基因在甲状腺微小乳头状癌中的表达:与组织学特征、区域淋巴结转移和预后的关系。
Sci Rep. 2019 Apr 9;9(1):5800. doi: 10.1038/s41598-019-41701-4.
7
Should we perform fine needle aspiration cytology of subcentimetre thyroid nodules? A retrospective review of local practice.我们应该对直径小于1厘米的甲状腺结节进行细针穿刺细胞学检查吗?对当地实践的回顾性研究。
Ultrasound. 2019 Feb;27(1):64-68. doi: 10.1177/1742271X18820556. Epub 2019 Jan 9.
8
Preliminary screening and analysis of metastasis-related lncRNA and co-expressed papillary thyroid carcinoma mRNA.与转移性相关的长链非编码RNA及共表达的甲状腺乳头状癌信使核糖核酸的初步筛选与分析
Oncol Lett. 2018 Sep;16(3):3715-3725. doi: 10.3892/ol.2018.9080. Epub 2018 Jul 5.
9
Study Protocol of Multicenter Prospective Cohort Study of Active Surveillance on Papillary Thyroid Microcarcinoma (MAeSTro).甲状腺微小乳头状癌主动监测多中心前瞻性队列研究(MAeSTro)方案
Endocrinol Metab (Seoul). 2018 Jun;33(2):278-286. doi: 10.3803/EnM.2018.33.2.278.
10
Genome-wide profiling identifies the THYT1 signature as a distinctive feature of widely metastatic Papillary Thyroid Carcinomas.全基因组分析确定THYT1特征为广泛转移的乳头状甲状腺癌的一个显著特征。
Oncotarget. 2017 Dec 1;9(2):1813-1825. doi: 10.18632/oncotarget.22805. eCollection 2018 Jan 5.
World J Surg. 2014 Mar;38(3):673-8. doi: 10.1007/s00268-013-2335-8.
4
BRAF(V600E) mutation analysis in papillary thyroid carcinoma: is it useful for all patients?甲状腺乳头状癌中的BRAF(V600E)突变分析:对所有患者都有用吗?
World J Surg. 2014 Mar;38(3):679-87. doi: 10.1007/s00268-013-2223-2.
5
Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation.患者年龄与观察中的甲状腺微小乳头状癌的进展显著相关。
Thyroid. 2014 Jan;24(1):27-34. doi: 10.1089/thy.2013.0367. Epub 2013 Nov 14.
6
BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma.液体细胞学处理的细针抽吸活检中 BRAF(V600E) 突变分析可预测甲状腺微小乳头状癌的双侧性和淋巴结受累。
Cancer Cytopathol. 2013 Jun;121(6):291-7. doi: 10.1002/cncy.21258. Epub 2012 Nov 28.
7
Relationship of biochemically persistent disease and thyroglobulin-doubling time to age at surgery in patients with papillary thyroid carcinoma.甲状腺癌患者的生化持续疾病和甲状腺球蛋白倍增时间与手术年龄的关系。
Endocr J. 2013;60(4):415-21. Epub 2012 Nov 23.
8
Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.研究肿瘤大小对甲状腺乳头状癌患者预后的影响。
Endocr J. 2012;59(6):457-64. doi: 10.1507/endocrj.ej12-0013. Epub 2012 Mar 8.
9
A novel definition of extrathyroidal invasion for patients with papillary thyroid carcinoma for predicting prognosis.一种用于预测甲状腺乳头状癌患者预后的甲状腺外侵犯的新定义。
World J Surg. 2012 Jun;36(6):1231-40. doi: 10.1007/s00268-012-1518-z.
10
Locoregional control of metastatic well-differentiated thyroid cancer by ultrasound-guided radiofrequency ablation.超声引导下射频消融治疗转移性高分化甲状腺癌的局部区域控制。
AJR Am J Roentgenol. 2011 Aug;197(2):W331-6. doi: 10.2214/AJR.10.5345.